Abstract
Observational evidence from the literature has shown an association between migraine headaches and patent foramen ovale (PFO). This observation has led to hypotheses that could explain the etiology of migraines in those with a PFO, including right-to-left shunting of venous agents such as serotonin that are normally broken down in the pulmonary circulation. Further evidence suggests that closure of a PFO may improve migraine symptoms and serve as an effective treatment modality for migraines. Several randomized controlled double-blinded studies are underway that will more definitively establish the role of specific devices in PFO closure in those suffering from migraines.
Original language | English |
---|---|
Pages (from-to) | 7-12 |
Number of pages | 6 |
Journal | Current Cardiology Reports |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2007 |